An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

Abstract Background Malignant pleural effusion (MPE) is a devastating sequela associated with cancer. Talc pleurodesis is a common treatment strategy for MPE but has been estimated to be unsuccessful in up to 20–50% of patients. Clinical failure of talc pleurodesis is thought to be due to poor dispe...

Full description

Bibliographic Details
Main Authors: Tim N. Beck, Alexander Y. Deneka, Louis Chai, Colin Kanach, Priya Johal, Nicolas J. Alvarez, Yanis Boumber, Erica A. Golemis, Glenn W. Laub
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Cancer
Subjects:
Lung cancer
Metastatic cancer
Talc
Pleurodesis
Malignant pleural effusion
Mouse model
Online Access:http://link.springer.com/article/10.1186/s12885-019-5777-z

Internet

http://link.springer.com/article/10.1186/s12885-019-5777-z

Similar Items